Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 4 Drug Alert (Caution in use): Aurum Pharmaceuticals - Amiodarone Hydrochloride 50 mg/ml concentrate for solution for injection or infusion - EL (09)A/36

Document details:

Type: Drug Alert
Series No: EL (09)A/36
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 2
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

DRUG ALERT

CLASS 4 MEDICINES DEFECT INFORMATION
Caution in Use
DISTRIBUTE TO HOSPITALS, WHOLESALERS AND RELEVANT CLINICS
23 December 2009 EL (09)A/36 Our ref:  MDR 45-12/09

Dear Healthcare Professional,

Aurum Pharmaceuticals

Amiodarone Hydrochloride 50 mg/ml

PL 12064/0123

Batch number Expiry date Pack size First distributed
80593 09/2010 10 ampoules 30/10/2008
80604 12/2010 10 ampoules 17/04/2009

Aurum Pharmaceuticals have informed us that particles have been found in some ampoules of batch 80593 but in addition batch 80604 is being included as a precautionary measure. An investigation is in progress to determine the nature of the particles and the root cause of the problem.

The SPC describes this product as ‘a clear pale yellow solution practically free from particulates’. Provided this product is inspected as per normal parenteral practices any unsuitable ampoules should be detected and discarded.

For medical information enquiries please contact Aurum Pharmaceuticals medical information on 01708 382791.

For enquiries relating to stock returns and credit please contact Aurum Pharmaceuticals customer services on 0800 028 7933.

Recipients of this Drug Alert are requested to bring it to the attention of relevant professionals by copy of this letter. Primary care trusts are asked to forward this to listed recipients, and relevant clinics and not to GPs and community pharmacists unless known to be relevant.

Yours faithfully

Ian Holloway
DMRC Manager

MHRA Distribution (further recipients by cascade): Distribute to hospitals, wholesalers and relevant clinics
Page last modified: 23 December 2009